Skip to main content
The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.

Publisher: Spandidos Publications

More about this publication?
Volume 6, Number 6, 1 June 1995

Articles

DISTINCT SIGNALING MEDIATES CHLORIDE SECRETION INDUCED BY TUMOR PROMOTER BILE-SALTS AND PHORBOL ESTERS IN HUMAN COLONIC CELLS
pp. 1159-1163(5)
Authors: HUANG, XP; HEYMAN, M; NATH, SK; CASTAGNA, M; DESJEUX, JF

Favourites:
ADD

LACK OF MICROSATELLITE INSTABILITY IN HUMAN PROSTATE-CANCER
pp. 1173-1176(4)
Authors: CHRISTIANS, FC; CONNOLLY, D; TSUCHIYA, K; TRUE, LD; LOEB, LA

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

SERUM INTERLEUKIN-10 LEVELS IN PATIENTS AFFECTED WITH MULTIPLE-MYELOMA - CORRELATION WITH THE MONOCLONAL COMPONENT AND DISEASE PROGRESSION
pp. 1189-1192(4)
Authors: AMEGLIO, F; ALVINO, S; TRENTO, E; MARCUCCI, M; PIMPINELLI, F; TONG, AW; GANDOLFO, GM; GRECO, C

Favourites:
ADD

MORPHOLOGICAL ASPECTS OF BASEMENT-MEMBRANES AND THEIR RECEPTORS IN BENIGN AND MALIGNANT NEOPLASMS (REVIEW)
pp. 1193-1202(10)
Authors: NERLICH, AG; HARAIDA, S; HAGEDORN, H; WIEST, I; SCHREINER, M; SCHLEICHER, ED

Favourites:
ADD

POLYNUCLEOTIDE VACCINATION FOR CANCER-TREATMENT (REVIEW)
pp. 1203-1208(6)
Authors: SPOONER, RA; BEL, SJ; EPENETOS, AA

Favourites:
ADD

THE ABERRANT P53 PROTEIN (REVIEW)
pp. 1209-1226(18)
Authors: FURIHATA, M; SONOBE, H; OHTSUKI, Y

Favourites:
ADD

HUMAN PROSTATIC-CARCINOMA CELL-LINE LNCAP DEGRADES LUTEINIZING-HORMONE-RELEASING HORMONE
pp. 1231-1236(6)
Authors: MAGGI, R; MORETTI, RM; Montagnani Marelli, M; PIMPINELLI, F; MOTTA, M

Favourites:
ADD

FLOW CYTOMETRIC CELLULAR DNA CONTENT AND LYMPH-NODE METASTASIS IN SQUAMOUS-CELL CARCINOMA OF THE ORAL CAVITY
pp. 1237-1242(6)
Authors: HEMMER, J; KREIDLER, J; VANHEERDEN, WFP; RAUBENHEIMER, EJ; SCHON, E

Favourites:
ADD

BENIGN AND MALIGNANT MYOEPITHELIOMA OF SALIVARY-GLAND - AN IMMUNOHISTOCHEMICAL EVALUATION
pp. 1243-1248(6)
Authors: TATEMOTO, Y; YONEDA, K; OHNO, A; OSAKI, T

Favourites:
ADD

MODEL SYSTEM FOR ISOLATION OF COMPETENT OVARIAN-CARCINOMA CELLS FROM FRESH TUMOR-TISSUE BY A MAGNETIC SEPARATION TECHNIQUE (MACS)
pp. 1249-1254(6)
Authors: HARBECK, N; SCHWARZE, S; SCHUREN, E; YAMAMOTO, N; MONIWA, N; SCHMITT, M; DETTMAR, P; NATHRATH, W; JANICKE, F; HOFLER, H; GRAEFF, H

Favourites:
ADD
Favourites:
ADD

PROGNOSTIC EVALUATION OF PATIENTS SUBMITTED TO SURGERY FOR MALIGNANT PLEURAL MESOTHELIOMA
pp. 1261-1265(5)
Authors: COLLEONI, M; BONI, L; CALABRO, F; MANENTE, P; NELLI, P; GAION, F; PANCHERI, F; SARTORI, F

Favourites:
ADD

GROWTH SUPPRESSIVE EFFICACY OF HUMAN LAK CELLS AGAINST HUMAN LUNG-CANCER IMPLANTED INTO SCID MICE
pp. 1271-1277(7)
Authors: TERAOKA, S; KYOIZUMI, S; SUZUKI, T; YAMAKIDO, M; AKIYAMA, M

Favourites:
ADD

PHASE-I STUDY OF SYNTHETIC MUC1 PEPTIDES IN BREAST-CANCER
pp. 1283-1289(7)
Authors: XING, PX; MICHAEL, M; APOSTOLOPOULOS, V; PRENZOSKA, J; MARSHALL, C; BISHOP, J; MCKENZIE, IFC

Favourites:
ADD
Favourites:
ADD

COMPARATIVE-STUDY OF INTRAMUSCULAR KETOROLAC TROMETHAMINE AND MORPHINE IN PATIENTS EXPERIENCING CANCER PAIN
pp. 1307-1311(5)
Authors: JAMEEL, A; STEIN, RC; RAWSON, NSB; HEDLEY, A; STUTTAFORD, J; COOMBES, RC

Favourites:
ADD

THE EXPRESSION OF P53 TUMOR-SUPPRESSOR PROTEIN DURING PROGRESSION OF GASTRIC AND COLORECTAL CARCINOMAS
pp. 1319-1323(5)
Authors: STARZYNSKA, T; BROMLEY, M; LANE, DP; STERN, PL

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content